Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications. (4th May 2017)

• Record Type: Journal Article
• Authors: Lourido, Lucía; Blanco, Francisco J.; Ruiz-Romero, Cristina
• Is Part Of: Expert review of proteomics. Volume 14:Number 5(2017)
• Page Start: 431
• Page End: 444
• Publication Date: 2017-05-04
• Subjects: Biomarkers -- pathogenesis -- patient stratification -- proteomics -- rheumatoid arthritis; Proteins -- Biotechnology -- Periodicals; Proteomics -- Periodicals; 572.6
• DOI: 10.1080/14789450.2017.1321481
• Languages: English
• ISSNs: 1478-9450

Abstract

ABSTRACT: Introduction : The heterogeneity of Rheumatoid Arthritis (RA) and the absence of clinical tests accurate enough to identify the early stages of this disease have hampered its management. Therefore, proteomics research is increasingly focused on the discovery of novel biological markers, which would not only be able make an early diagnosis, but also to gain insight into the different pathological mechanisms underlying the heterogeneity of RA and also to stratify patients, which is critical to enabling effective treatments. Areas covered : The proteomic approaches that have been utilised to provide knowledge about RA pathogenesis, and to identify biomarkers for RA diagnosis, prognosis, disease monitoring and prediction of response to therapy, are summarized. Expert commentary : Although each proteomic study is unique in its design, all of them have contributed to the understanding of RA pathogenesis and the discovery of promising biomarkers for patient stratification, which would improve clinical care of RA patients. Still, efforts need to be made to validate these findings and translate them into clinical practice.